510(k) K220493

Plaxpot Multi Plasma by Gcs Co. Limited — Product Code QVJ

K220493 is an FDA 510(k) premarket notification submitted by Gcs Co. Limited for the device "Plaxpot Multi Plasma". The FDA issued a decision of Substantially Equivalent on October 27, 2023. The device falls under product code QVJ (Low Power Electrosurgical Devices For Skin Lesion Destruction), a Class II device regulated under 21 CFR 878.4400.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
October 27, 2023
Date Received
February 22, 2022
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Low Power Electrosurgical Devices For Skin Lesion Destruction
Device Class
Class II
Regulation Number
878.4400
Review Panel
SU
Submission Type

For the removal and destruction of skin lesions in general dermatological procedures, also referred to as Plasma Pen Devices, which generates electrical arc in the ambient air between an electrical probe tip and the skin and cause intended tissue damage for the removal and destruction of skin lesions